Torigen Pharmaceuticals is focused on veterinary cancer care. Their product, VetiVax, is a revolutionary cancer immunotherapy that uses the patient's own tumor cells to create a personalized treatment that educates the immune system to recognize the tumor as foreign. 

Veterinary & Pet

Torigen Pharmaceuticals

Ashley Kalinauskas

Troy Gobbett, PMP

Kathryn Deeley

John Kallassy

Christine McCoy

Chelsea Greenberg

Mark Suckow

Michael Lucroy

Sean Fitzgerald

Ryan Clauson

The Sales and Business Development team at Torigen Pharmaceuticals drives the growth and market expansion of VetiVax by building strong relationships with veterinary clinics and animal health professionals. They focus on educating stakeholders about the benefits of personalized cancer immunotherapy, facilitating sales training, and developing strategic partnerships to enhance product adoption and improve veterinary cancer care.

Sales and Business Development

Leadership Team

Research and Development

Sales and Business Development

About

Team members

Other teams at Torigen Pharmaceuticals

Leadership Team

Research and Development